Please use this identifier to cite or link to this item:
Title: Transducing system operated by adenosine A2A receptors to facilitate acetylcholine release in the rat hippocampus
Authors: Rebola, Nelson 
Oliveira, Catarina R. 
Cunha, Rodrigo A. 
Keywords: Adenosine; A2A receptor; Hippocampus; Acetylcholine release; Nerve terminal; Synaptosome
Issue Date: 2002
Citation: European Journal of Pharmacology. 454:1 (2002) 31-38
Abstract: Although molecular biology studies indicate the presence of adenosine A2A receptors in the rat hippocampus, the pharmacological characterization of adenosine A2A receptor binding and of its putative facilitatory effects has revealed features essentially different from these found for adenosine A2A receptors in most preparations. We now confirmed that activation of adenosine A2A receptors with 2-[4-(2-p-carboxyethyl)phenylamino]-5'-N-ethylcarboxamidoadenosine (CGS 21680, 1-30 nM) or 2-hexynyl-5'-N-ethylcarboxamidoadenosine (HENECA, 3-100 nM) facilitated the veratridine-evoked [3H]acetylcholine release from hippocampal synaptosomes with a maximal effect of 14±2% and 16±2%, respectively. These effects were prevented by the adenosine A2A receptor antagonists, 4-(2-[7-amino-2-{2-furyl}{1,2,4}-triazolo{2,3a}{1,3,5}triazin-5-yl-amino]ethyl)phenol (ZM 241385, 20 nM) and 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH 58261, 20 nM), but not by the adenosine A1 receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM). Adenosine A2A receptors may activate adenylate cyclase and protein kinase A since CGS 21680 (10 nM) facilitation of [3H]acetylcholine release was occluded by 8-bromo-cAMP (0.5 mM) and forskolin (10 [mu]M) and prevented by H-89 (1 [mu]M), but unaffected by phorbol-12,13-didecanoate (250 nM) or bisindolylmaleimide I (1 [mu]M). The existence of adenosine A2A receptors in hippocampal nerve terminals was further confirmed by a Western blot immunoreactivity qualitatively identical to that found in the striatum. This constitutes the first pharmacological identification of canonical adenosine A2A receptors coupling to the expected cAMP/protein kinase A pathway in the hippocampus with the expected immunoreactivity.
Rights: openAccess
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais

Files in This Item:
File Description SizeFormat
filedfe5de0c53974a069802404a2913fe29.pdf189.54 kBAdobe PDFView/Open
Show full item record

Page view(s) 50

checked on Jul 8, 2020

Download(s) 50

checked on Jul 8, 2020

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.